Identification of significant risks in pediatric acute lymphoblastic leukemia (ALL) through machine learning (ML) approach

被引:27
|
作者
Mahmood, Nasir [1 ,2 ]
Shahid, Saman [3 ]
Bakhshi, Taimur [3 ]
Riaz, Sehar [4 ,5 ]
Ghufran, Hafiz [4 ,5 ]
Yaqoob, Muhammad [5 ,6 ]
机构
[1] Univ Hlth Sci UHS, Dept Biochem Human Genet & Mol Biol, Lahore, Pakistan
[2] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada
[3] Natl Univ Comp & Emerging Sci NUCES, Fdn Adv Sci & Technol FAST, Dept Sci & Humanities, Lahore, Pakistan
[4] Childrens Hosp, Sch Allied Hlth Sci, Lahore, Pakistan
[5] Inst Child Hlth, Lahore, Pakistan
[6] Childrens Hosp, Dept Med Genet, Lahore, Pakistan
关键词
Pediatric ALL; Machine learning (ML); Classification and regression trees (CART); Platelets; Hemoglobin; Environmental factors; CHILDHOOD LEUKEMIA; GENETIC POLYMORPHISMS; DRINKING-WATER; CHROMOSOMAL-ABNORMALITIES; THROMBOTIC COMPLICATIONS; SOCIOECONOMIC-STATUS; CHILDREN; SUSCEPTIBILITY; POPULATION; MUTATIONS;
D O I
10.1007/s11517-020-02245-2
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
Pediatric acute lymphoblastic leukemia (ALL) through machine learning (ML) technique was analyzed to determine the significance of clinical and phenotypic variables as well as environmental conditions that can identify the underlying causes of child ALL. Fifty pediatric patients (n = 50) included who were diagnosed with acute lymphoblastic leukemia (ALL) according to the inclusion and exclusion criteria. Clinical variables comprised of the blood biochemistry (CBC, LFTs, RFTs) results, and distribution of type of ALL, i.e., T ALL or B ALL. Phenotypic data included the age, sex of the child, and consanguinity, while environmental factors included the habitat, socioeconomic status, and access to filtered drinking water. Fifteen different features/attributes were collected for each case individually. To retrieve most useful discriminating attributes, four different supervised ML algorithms were used including classification and regression trees (CART), random forest (RM), gradient boosted machine (GM), and C5.0 decision tree algorithm. To determine the accuracy of the derived CART algorithm on future data, a ten-fold cross validation was performed on the present data set. The ALL was common in children of age below 5 years in male patients whole belonged to middle class family of rural areas. (B-ALL) was most frequent as compared with T-ALL. The consanguinity was present in 54% of cases. Low levels of platelets and hemoglobin and high levels of white blood cells were reported in child ALL patients. CART provided the best and complete fit for the entire data set yielding a 99.83% model fit accuracy, and a misclassification of 0.17% on the entire sample space, while C5.0 reported 98.6%, random forest 94.44%, and gradient boosted machine resulted in 95.61% fitting. The variable importance of each primary discriminating attribute is platelet 43%, hemoglobin 24%, white blood cells 4%, and sex of the child 4%. An overall accuracy of 87.4% was recorded for the classifier. Platelet count abnormality can be considered as a major factor in predicting pediatric ALL. The machine learning algorithms can be applied efficiently to provide details for the prognosis for better treatment outcome. Graphical Identification of significant risks in pediatric acute lymphoblastic leukemia (ALL) through machine learning (ML) approach.
引用
收藏
页码:2631 / 2640
页数:10
相关论文
共 50 条
  • [1] Identification of significant risks in pediatric acute lymphoblastic leukemia (ALL) through machine learning (ML) approach
    Nasir Mahmood
    Saman Shahid
    Taimur Bakhshi
    Sehar Riaz
    Hafiz Ghufran
    Muhammad Yaqoob
    Medical & Biological Engineering & Computing, 2020, 58 : 2631 - 2640
  • [2] Determining the Significant Prognostic Factors for the Recurrence of Pediatric Acute Lymphoblastic Leukemia Using a Competing Risks Approach
    Saeedi, Anahita
    Baghestani, Ahmadreza
    Maboudi, Aliakbar Khadem
    Farhangi, Hamid
    IRANIAN JOURNAL OF MEDICAL SCIENCES, 2020, 45 (04) : 304 - 310
  • [3] PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
    Anak, S. Sema
    LEUKEMIA RESEARCH, 2014, 38 : S22 - S23
  • [4] TRAJECTORY OF HYPERGLYCEMIA IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
    Lederer, Sophie
    DeGroote, Nicholas
    Josh, Vivek
    West, Zachary
    Castellino, Sharom
    Miller, Tamara
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [5] A Machine Learning Approach for Predicting the Occurrence of Asparaginase-Associated Pancreatitis in Pediatric Patients with Acute Lymphoblastic Leukemia
    Yoon, Suhyun
    Kim, Hyery
    Youk, Dongbin
    Song, Jong Keon
    Kang, Sung Han
    Koh, Kyung-Nam
    Im, Ho Joon
    BLOOD, 2023, 142
  • [6] Significant difference in outcome for adolescents with acute lymphoblastic leukemia (ALL) treated on pediatric versus adult ALL protocols.
    de Bont, JM
    van der Holt, B
    Dekker, AW
    den Berg, AVDDV
    Sonneveld, P
    Pieters, R
    BLOOD, 2003, 102 (11) : 222A - 223A
  • [7] Epigenetic Profiling and Machine Learning for Enhanced Risk Stratification in Pediatric Acute Lymphoblastic Leukemia
    Mosquera Orgueira, Adrian
    Krali, Olga
    Peleteiro Raindo, Andres
    Diaz Arias, Jose Angel
    Gonzalez Perez, Marta Sonia
    Perez Encinas, Manuel
    Fernandez Sanmartin, Manuel
    Alonso Vence, Natalia
    Sinnett, Daniel
    Heyman, Mats
    Lonnerholm, Gudmar
    Noren-Nystrom, Ulrika
    Schmiegelow, Kjeld
    Nordlund, Jessica
    BLOOD, 2023, 142
  • [8] Pattern of Chromosomal Abnormalities in Pediatric Acute Lymphoblastic Leukemia (ALL)
    Somanath, Padhi
    RajLaxmi, Sarangi
    Pranati, Mohanty
    Rupa, Das
    Sukumar, Chakravarty
    Raghumani, Mohanty
    KUWAIT MEDICAL JOURNAL, 2011, 43 (02): : 118 - 124
  • [9] Characterization and identification of leukemia initiating cells in pediatric acute lymphoblastic leukemia
    Luca Trentin
    Manon Queudeville
    Sarah Mirjam Eckhoff
    Nabiul Hasan
    Klaus-Michael Debatin
    Lueder Hinrich Meyer
    Molecular and Cellular Pediatrics, 1 (Suppl 1)
  • [10] MicroRNA expression and activity in pediatric acute lymphoblastic leukemia (ALL)
    de Oliveira, Jaqueline C.
    Brassesco, Maria Sol
    Scrideli, Carlos Alberto
    Tone, Luiz Gonzaga
    Narendran, Aru
    PEDIATRIC BLOOD & CANCER, 2012, 59 (04) : 599 - 604